Northwest & Ethical Investments L.P.
Position in VRTX — Vertex Pharmaceuticals Inc / Ma
CIK 2033536
TORONTO, A6
Position in VRTX
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$3,310,208
-$2,022,372 QoQ
Shares Held
6,664
-44.2% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
#553
of 1,726 holders
Holding Since
Dec 2020
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Northwest & Ethical Investments L.P. holds $4,060,177 across 9 Biotechnology names. VRTX ranks #1 (81.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
6,664 | $3,310,208 | |
| 2 | QURE |
uniQure N.V.
|
2,823 | $130,027 | |
| 3 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
1,100 | $122,133 | |
| 4 | ZYME |
Zymeworks Inc.
|
4,630 | $121,028 | |
| 5 | MIRM |
Mirum Pharmaceuticals, Inc.
|
896 | $104,894 | |
| 6 | CAI |
Caris Life Sciences, Inc.
|
4,727 | $84,235 | |
| 7 | CGON |
CG Oncology, Inc.
|
1,185 | $84,194 | |
| 8 | ABVX |
Abivax S.A.
|
467 | $62,232 |
All Filings in VRTX
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,310,208 | 6,664 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $5,332,580 | 11,942 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $5,034,109 | 11,104 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $5,997,966 | 15,315 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $6,717,622 | 15,089 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $7,058,494 | 14,559 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $11,203,919 | 27,822 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $12,389,731 | 26,640 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $11,269,903 | 24,044 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $10,050,632 | 24,044 | Shares | Sole | 2025-07-09 | |
| 2023-12-31 | $17,436,864 | 42,854 | Shares | Sole | 2025-07-09 | |
| 2023-09-30 | $13,393,206 | 38,515 | Shares | Sole | 2025-07-09 | |
| 2023-06-30 | $7,635,391 | 21,697 | Shares | Sole | 2025-07-09 | |
| 2023-03-31 | $5,007,722 | 15,894 | Shares | Sole | 2025-07-09 | |
| 2022-12-31 | $1,260,235 | 4,364 | Shares | Sole | 2025-07-09 | |
| 2022-09-30 | $3,808,609 | 13,154 | Shares | Sole | 2025-07-09 | |
| 2022-06-30 | $3,808,391 | 13,515 | Shares | Sole | 2025-07-09 | |
| 2022-03-31 | $3,527,009 | 13,515 | Shares | Sole | 2025-07-09 | |
| 2021-12-31 | $4,752,363 | 21,641 | Shares | Sole | 2025-07-09 | |
| 2021-03-31 | $1,410,967 | 6,566 | Shares | Sole | 2025-07-09 | |
| 2020-12-31 | $619,919 | 2,623 | Shares | Sole | 2025-07-08 | |
| No filing history on record for this holder in this stock. | ||||||